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ABSTRACT
A number of herbal preparations are used throughout the world for the management of the hepatic disorders. However,
many of them have not been investigated for their described effects. Cassia fistula Linn. is one such drug used in the
treatment of hepatitis in folk medicine. Therefore, an attempt was made to investigate the hepatoprotective effect of
leaves and bark of Cassia fistula against carbon tetrachloride (CCl4) induced hepatotoxicity in rats. Sixty albino
Wistar rats were divided into six equal groups of 10. Four groups received extracts leaves/bark of Cassia fistula and
intraperitoneal (i.p.) CCl4 (0.2 ml/100 g) either before or after administration of extracts. Two groups were controls,
one treated with CCl4 and one with normal saline. Liver damage was assessed by plasma concentration of bilirubin
and enzyme activities of aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase. Treatment
with aqueous extract of leaves and bark significantly reduced CCl4 -induced elevation in plasma enzyme and bilirubin
concentration in rats. This study demonstrated that CCl4 -induced liver damage in rats can be ameliorated by treatment
of extracts from leaves and bark.
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INTRODUCTION
Liver is the key organ for detoxification and disposition of endogenous substances. It is continuously and widely
exposed to xenobiotics, hepatotoxins, and chemotherapeutic agents that lead to impairment of its functions1. Cassia
fistula (Leguminoceae) is known as amaltas (Hindi), bahava (Marathi). It is a deciduous, medium sized tree upto 24 m
in height with straight bole upto 15 m, found both wild and cultivated almost throughout India. The leaves reported to
contain flavonoids like quercetin, kaempferol along with anthraquinone glycosides while bark is rich in flavonoids
like lupeol, epicatechin and tannins2. Literature survey revealed that no scientific study is reported regarding its
hepatoprotective activity of Cassia fistula. Therefore, the present study was conducted to investigate its
hepatoprotective activity.
MATERIAL & METHODS
Plant Material

Leaves and bark of Cassia fistula were obtained from Amaravati District, Maharashtra. The plant samples were
identified and authenticated in the Herbarium by botanist Dr. Prabha Y. Bhogaonkar, VMV, Botany Department,
Amaravati, Maharashtra, India. The leaves and bark were macerated by using water as a menstrum. The obtained
extract was dried and concentrated under freezed drier and kept tied closed into container.
Animals
The Institutional Animal Ethics Committee approved the animal studies. It includes Albino Wistar rats of either sex,
weighing 180-200 g. All animals were given standard diet and water ad libitum. They were maintained at a relative
humidity of 65 to 86%, a temperature of 23 to 25°C, and in a schedule of 12 h of light and 12 h of dark. Rats were
weighed at the beginning and end of the study.
Chemicals
CCl4 was obtained from Sigma-Aldrich. All other chemicals used were of analytical grade.
Assessment of Hepatoprotective Activity
Sixty animals were randomly divided equally into six groups of 10 each.
Group 1 (controls): received normal saline orally (0.2 ml/100 g) for 16 consecutive days.
Group 2 (pretreatment experiment-leaves extract): allowed free access to aqueous extract of leaves ad libitum for 28
consecutive days and treated with i.p. CCl4 on Days 14, 15, and 16 of the treatment period.
Group 3 (post-treatment experiment-leaves extract): given aqueous extract of leaves ad libitum for 14 consecutive
days and treated with i.p. CCl4 on Days 1, 2, and 3 of the treatment period.
Group 4 (pretreatment experiment-bark extract): allowed aqueous extract of bark ad libitum for 28 consecutive days
and treated with i.p. CCl4 on Days 14, 15, and 16 of the treatment period.
Group 5 (post-treatment experiment-bark extract): given aqueous extract of bark ad libitum for 14 consecutive days
and treated with i.p. CCl4 on Days 1, 2, and 3 of the treatment period.
Group 6 (CCl4 -treated control): injected i.p. with a fresh mixture of equal volumes of CCl4 and olive oil for three
consecutive days at the dose of 0.2 ml/100 g of body weight/day.
Twenty-four hours after the last treatment, the rats were euthanized by injecting i.p. sodium pentobarbitone (100 g/
kg). Hepatoprotective activity was calculated3.
Hepatoprotective activity (%) = 1 - (PC - S)/(C - S) x 100 where PC, C, and S are the measurable variables in rats
treated with Cassia fistula leaves/bark extract with CCl4, CCl4, and saline-treated animals, respectively.
Blood Sampling
Blood was collected in heparinized tubes from the inner canthus on the 29th day or the 16th day in the pre or posttreated groups, respectively. Plasma was separated by centrifugation at 900 rpm for 10 min at 4°C and used for

determining the activities of aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase
(ALP), and bilirubin concentration using the Hitachi autoanalyzer-902.
Statistical Analysis
Values reported are means ± SE (n = 10). Experimental results were statistically analyzed using the Student's t -test
followed by ANOVA. P value less than 0.01 considered significant.
Results
The CCl4 -treated animals exhibited a significant increase (P < 0.01) in plasma enzyme activity and bilirubin
concentration compared with saline-treated control rats (Table 1).
Table 1: Effect of pre- and post- treatment with aqueous Cassia fistula leaves and bark on CCl4 induced liver
damaged in albino Wistar rats.
Treatment

Aspartate

Alanine

aminotransferase (U/L) aminotransferase

Alkaline

Bilirubin (µmole/

phosphatase (U/L) L)

(U/L)
Control

108.6±3.29

35.43±1.33

156.2±2.64

0.17±.03

CF Leaves pretreatment

134.6±3.12

46.80±1.78*

181.5±1.98*

0.19±.01

CF Leaves post treatment

124.0±4.27*

44.31±0.76*

193.2±4.82*

0.20±.01

CF Bark pretreatment

163.1±4.63*

59.60±1.56*

180.90±3.03*

0.21±.01

CF Bark post treatment

158.7±6.45*

56.90±1.23*

171.8±10.13

0.20±0.00

Carbon tetrachloride

283.4±2.99*

85.6±1.99*

253.6±5.45*

3.30±0.07*

CF: Cassia fistula; Data are expressed as ± SE (n=10), * Significantly different than control at P<0.01.

A significant reduction was found in elevated AST, ALT, and ALP values in rats subjected to both pre- and posttreatments with the aqueous extracts of both leaves and bark. Liver enzyme values were higher in the four
experimental groups than in the saline-treated controls, but the liver enzyme values were decreased to about half of
those found in CCl4 -treated control animals for all liver function tests except bilirubin. Expressed in percentage of
protection provided, both Cassia fistula leaves and bark given pre- or post-treatment were hepatoprotective (Table 2).
Table 2: Hepatoprotective activity of leaves and bark of Cassia fistula in CCl4 induced hepatotoxicity in albino
Wistar rats.

Clinical chemistry liver

Aspartate

Alanine

Alkaline

function indicator

aminotransferase

aminotransferase

phosphatase

76.60

75.16

99.23

89.89

82.32

61.97

99.07

68.66

51.11

71.37

96.03

71.23

54.99

82.54

99.03

CF Leaves pretreatment 83.06

Bilirubin

(% protection)
CF Leaves post
treatment (% protection)
CF Bark pretreatment
(% protection)
CF Bark post treatment
(% protection)

CF: Cassia fistula; % Protection = 1-(PC-S)/ (C-S) × 100, where PC, C and S are the measurable variables in rats treated with CF leaves or
bark extract with CCl4, CCl4 and saline treated animals respectively

Discussion
Liver cirrhosis induced by CCl4 is perhaps the best-studied model of liver cirrhosis4 .Several mechanisms underlying
this toxicity have been suggested5. The reduction of CCl4 -induced elevated plasma activities of AST, ALT, ALP, and
bilirubin level in animals pre- and post-treated with the aqueous extracts of Cassia fistula leaves and bark showed
their ability to restore the normal functional status of the poisoned liver and also to protect against subsequent CCl4
hepatotoxicity. The mechanism by which the fruits pulp and seeds induces its hepatoprotective activity is not certain.
The inactive metabolite (CCl4), is transformed to a free radical through the microsomal cytochrome P-450-dependent
enzyme, resulting in activation of CCl4 toxicity. Hepatoprotective activity of any drug is the ability of its constituents
to inhibit the aromatase activity of cytochrome P-450, thereby favoring liver regeneration. On that basis, it is
suggested that flavonoids in Cassia fistula could be a factor for exhibiting the hepatoprotective activity.
Conclusion
This study clearly demonstrates that aqueous extracts of Cassia fistula leaves and bark are effective in the treatment
and prevention of CCl4 -induced hepatic cytotoxicity. The data suggest that the daily oral consumption of an aqueous
extract of the Cassia fistula leaves and bark may alleviate CCl4 toxicity and provide protection to liver. This research
work supports its traditional use for the treatment of hepatic disorder.
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